Based on expert opinions from the top commentators in the field, the report offers insight into how European biosimilar markets have evolved. It also includes up to the minute US case studies, insight into specific approaches to biosimilars intended for multiple diseases and which strategies have proven most effective-and why. Learn more here. (Source: FirstWord, 11/2013).
You are here: / / Commercialisation Of Biosimilars: Strategies For Market Penetration